3M CO (MMM) Free cash flow
- Free cash flow · 12 months (USD): Value $3.98B; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 15.83%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $3.98B | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $4.90B − $914.00M ≈ $3.98B |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 15.83% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $3.98B ÷ $25.18B × 100 ≈ 15.83% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $4.90B | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.63× | Operating cash flow / net income. Period ending 2026-06-30. $4.90B ÷ $3.00B ≈ 1.63× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 4.90B USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 914.00M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 3.98B USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 25.18B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 3.00B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.98B | (m) | $4.90B | $914.00M | (m) | $25.18B | (m) | $3.00B | (m) | (m) | 15.83% | 1.63× |
| 2026-03-31 | $2.06B | (m) | $2.96B | $899.00M | (m) | $25.02B | (m) | $2.79B | (m) | (m) | 8.23% | 1.06× |
| 2025-12-31 | $1.40B | (m) | $2.31B | $910.00M | (m) | $24.95B | (m) | $3.25B | (m) | (m) | 5.60% | 0.71× |
| 2025-09-30 | $1.59B | (m) | $2.54B | $953.00M | (m) | $24.82B | (m) | $3.40B | (m) | (m) | 6.40% | 0.75× |
| 2025-06-30 | $-1.98B | (m) | $-1.00B | $981.00M | (m) | $24.60B | (m) | $3.94B | (m) | (m) | -8.06% | -0.25× |
| 2025-03-31 | $-69.00M | (m) | $973.00M | $1.04B | (m) | $24.51B | (m) | $4.36B | (m) | (m) | -0.28% | 0.22× |
| 2024-12-31 | $638.00M | (m) | $1.82B | $1.18B | (m) | $24.57B | (m) | $4.17B | (m) | (m) | 2.60% | 0.44× |
| 2024-09-30 | $739.00M | (m) | $1.99B | $1.25B | (m) | $32.64B | (m) | $4.39B | (m) | (m) | 2.26% | 0.45× |
| 2024-06-30 | $4.28B | (m) | $5.68B | $1.41B | (m) | $32.61B | (m) | $943.00M | (m) | (m) | 13.11% | 6.03× |
| 2024-03-31 | $4.66B | (m) | $6.17B | $1.51B | (m) | $32.65B | (m) | $-7.04B | (m) | (m) | 14.26% | -0.88× |
| 2023-12-31 | $5.07B | (m) | $6.68B | $1.61B | (m) | $32.68B | (m) | $-7.00B | (m) | (m) | 15.50% | -0.95× |
| 2023-09-30 | $4.85B | (m) | $6.62B | $1.76B | (m) | $32.75B | (m) | $-7.40B | (m) | (m) | 14.82% | -0.89× |
| 2023-06-30 | $4.44B | (m) | $6.24B | $1.79B | (m) | $33.05B | (m) | $-1.47B | (m) | (m) | 13.44% | -4.26× |
| 2023-03-31 | $4.05B | (m) | $5.86B | $1.80B | (m) | $33.43B | (m) | $5.45B | (m) | (m) | 12.13% | 1.07× |
| 2022-12-31 | $3.84B | (m) | $5.59B | $1.75B | (m) | $34.23B | (m) | $5.78B | (m) | (m) | 11.22% | 0.97× |
| 2022-09-30 | $3.88B | (m) | $5.67B | $1.80B | (m) | $34.76B | (m) | $6.58B | (m) | (m) | 11.15% | 0.86× |
| 2022-06-30 | $4.31B | (m) | $6.02B | $1.71B | (m) | $35.09B | (m) | $4.15B | (m) | (m) | 12.28% | 1.45× |
| 2022-03-31 | $5.06B | (m) | $6.78B | $1.72B | (m) | $35.33B | (m) | $5.60B | (m) | (m) | 14.32% | 1.21× |
| 2021-12-31 | $5.85B | (m) | $7.45B | $1.60B | (m) | $35.35B | (m) | $5.92B | (m) | (m) | 16.55% | 1.26× |
| 2021-09-30 | $6.50B | (m) | $7.96B | $1.47B | (m) | $35.33B | (m) | $5.92B | (m) | (m) | 18.39% | 1.34× |
| 2021-06-30 | $7.08B | (m) | $8.57B | $1.49B | (m) | $34.73B | (m) | $5.92B | (m) | (m) | 20.37% | 1.45× |
| 2021-03-31 | $7.11B | (m) | $8.59B | $1.48B | (m) | $32.96B | (m) | $5.70B | (m) | (m) | 21.57% | 1.51× |
| 2020-12-31 | $6.61B | (m) | $8.11B | $1.50B | (m) | $32.18B | (m) | $5.38B | (m) | (m) | 20.54% | 1.51× |
| 2020-09-30 | $6.32B | (m) | $7.94B | $1.62B | (m) | $31.71B | (m) | $4.96B | (m) | (m) | 19.93% | 1.60× |
| 2020-06-30 | $5.88B | (m) | $7.48B | $1.60B | (m) | $31.35B | (m) | $5.13B | (m) | (m) | 18.75% | 1.46× |
| 2020-03-31 | $5.59B | (m) | $7.24B | $1.64B | (m) | $32.35B | (m) | $4.97B | (m) | (m) | 17.30% | 1.46× |
| 2019-12-31 | $5.37B | (m) | $7.07B | $1.70B | (m) | $32.14B | (m) | $4.57B | (m) | (m) | 16.71% | 1.55× |
| 2019-09-30 | $5.30B | (m) | $6.99B | $1.69B | (m) | $31.97B | (m) | $4.95B | (m) | (m) | 16.57% | 1.41× |
| 2019-06-30 | $5.39B | (m) | $7.11B | $1.72B | (m) | $32.13B | (m) | $4.91B | (m) | (m) | 16.77% | 1.45× |
| 2019-03-31 | $5.68B | (m) | $7.34B | $1.66B | (m) | $32.35B | (m) | $5.64B | (m) | (m) | 17.56% | 1.30× |
| 2018-12-31 | $4.86B | (m) | $6.44B | $1.58B | (m) | $32.77B | (m) | $5.35B | (m) | (m) | 14.84% | 1.20× |
| 2018-09-30 | $4.54B | (m) | $6.04B | $1.50B | (m) | $32.81B | (m) | $4.53B | (m) | (m) | 13.83% | 1.34× |
| 2018-06-30 | $4.20B | (m) | $5.65B | $1.45B | (m) | $32.83B | (m) | $4.41B | (m) | (m) | 12.79% | 1.28× |
| 2018-03-31 | $4.00B | (m) | $5.39B | $1.39B | (m) | $32.25B | (m) | $4.14B | (m) | (m) | 12.42% | 1.30× |
| 2017-12-31 | $4.87B | (m) | $6.24B | $1.37B | (m) | $31.66B | (m) | $4.86B | (m) | (m) | 15.37% | 1.28× |
| 2017-09-30 | $5.24B | (m) | $6.59B | $1.35B | (m) | $31.00B | (m) | $5.49B | (m) | (m) | 16.90% | 1.20× |
| 2017-06-30 | $5.38B | (m) | $6.75B | $1.37B | (m) | $30.53B | (m) | $5.39B | (m) | (m) | 17.60% | 1.25× |
| 2017-03-31 | $5.00B | (m) | $6.39B | $1.39B | (m) | $30.39B | (m) | $5.10B | (m) | (m) | 16.45% | 1.25× |
| 2016-12-31 | $5.24B | (m) | $6.66B | $1.42B | (m) | $30.11B | (m) | $5.05B | (m) | (m) | 17.41% | 1.32× |
| 2016-09-30 | $5.36B | (m) | $6.79B | $1.43B | (m) | $30.08B | (m) | $4.93B | (m) | (m) | 17.82% | 1.38× |
| 2016-06-30 | $5.11B | (m) | $6.55B | $1.44B | (m) | $30.08B | (m) | $4.90B | (m) | (m) | 16.99% | 1.34× |
| 2016-03-31 | $5.12B | (m) | $6.60B | $1.48B | (m) | $30.11B | (m) | $4.91B | (m) | (m) | 16.99% | 1.34× |
| 2015-12-31 | $4.96B | (m) | $6.42B | $1.46B | (m) | $30.27B | (m) | $4.83B | (m) | (m) | 16.38% | 1.33× |
| 2015-09-30 | $4.76B | (m) | $6.26B | $1.50B | (m) | $30.70B | (m) | $4.97B | (m) | (m) | 15.51% | 1.26× |
| 2015-06-30 | $4.79B | (m) | $6.31B | $1.52B | (m) | $31.12B | (m) | $4.98B | (m) | (m) | 15.40% | 1.27× |
| 2015-03-31 | $5.12B | (m) | $6.61B | $1.49B | (m) | $31.57B | (m) | $4.95B | (m) | (m) | 16.23% | 1.34× |
| 2014-12-31 | $5.13B | (m) | $6.63B | $1.49B | (m) | $31.82B | (m) | $4.96B | (m) | (m) | 16.13% | 1.34× |
| 2014-09-30 | $4.89B | (m) | $6.44B | $1.55B | (m) | $31.67B | (m) | $4.88B | (m) | (m) | 15.44% | 1.32× |
| 2014-06-30 | $4.29B | (m) | $5.88B | $1.58B | (m) | $31.45B | (m) | $4.81B | (m) | (m) | 13.66% | 1.22× |
| 2014-03-31 | $4.28B | (m) | $5.92B | $1.63B | (m) | $31.07B | (m) | $4.74B | (m) | (m) | 13.78% | 1.25× |
| 2013-12-31 | $4.15B | (m) | $5.82B | $1.67B | (m) | $30.87B | (m) | $4.66B | (m) | (m) | 13.45% | 1.25× |
| 2013-09-30 | $3.93B | (m) | $5.56B | $1.63B | (m) | $30.69B | (m) | $4.55B | (m) | (m) | 12.82% | 1.22× |
| 2013-06-30 | $4.17B | (m) | $5.76B | $1.58B | (m) | $30.27B | (m) | $4.48B | (m) | (m) | 13.79% | 1.29× |
| 2013-03-31 | $3.92B | (m) | $5.47B | $1.55B | (m) | $30.05B | (m) | $4.45B | (m) | (m) | 13.04% | 1.23× |
| 2012-12-31 | $3.82B | (m) | $5.30B | $1.48B | (m) | $29.90B | (m) | $4.44B | (m) | (m) | 12.76% | 1.19× |
| 2012-09-30 | $3.81B | (m) | $5.30B | $1.49B | (m) | $29.61B | (m) | (m) | (m) | (m) | 12.86% | (m) |
| 2012-06-30 | $3.85B | (m) | $5.32B | $1.47B | (m) | $29.64B | (m) | (m) | (m) | (m) | 12.97% | (m) |
| 2012-03-31 | $3.97B | (m) | $5.38B | $1.41B | (m) | $29.79B | (m) | (m) | (m) | (m) | 13.33% | (m) |
| 2011-12-31 | $3.90B | (m) | $5.28B | $1.38B | (m) | $29.61B | (m) | (m) | (m) | (m) | 13.19% | (m) |
| 2011-09-30 | $3.79B | (m) | $5.18B | $1.39B | (m) | $29.23B | (m) | (m) | (m) | (m) | 12.96% | (m) |
| 2011-06-30 | $3.86B | (m) | $5.14B | $1.28B | (m) | $28.57B | (m) | $4.28B | (m) | (m) | 13.50% | 1.20× |
| 2011-03-31 | $3.66B | (m) | $4.83B | $1.17B | (m) | $27.63B | (m) | $4.24B | (m) | (m) | 13.25% | 1.14× |
| 2010-12-31 | $4.08B | (m) | $5.17B | $1.09B | (m) | $26.66B | (m) | $4.08B | (m) | (m) | 15.31% | 1.27× |
| 2010-09-30 | $3.75B | (m) | $4.59B | $839.00M | (m) | $26.07B | (m) | $4.09B | (m) | (m) | 14.37% | 1.12× |
| 2010-06-30 | $4.21B | (m) | $5.00B | $786.00M | (m) | $25.39B | (m) | $3.94B | (m) | (m) | 16.59% | 1.27× |
| 2010-03-31 | $4.51B | (m) | $5.33B | $816.00M | (m) | $24.38B | (m) | $3.60B | (m) | (m) | 18.51% | 1.48× |
| 2009-12-31 | $4.04B | (m) | $4.94B | $903.00M | (m) | $23.12B | (m) | $3.19B | (m) | (m) | 17.46% | 1.55× |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $3.06B | (m) | $4.53B | $1.47B | (m) | $25.27B | (m) | $3.46B | (m) | (m) | 12.12% | 1.31× |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $2.82B | (m) | $4.25B | $1.42B | (m) | $24.46B | (m) | $4.10B | (m) | (m) | 11.54% | 1.04× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |